基于脂质的纳米颗粒作为癌症免疫治疗的药物输送系统
Yang Hao1,2,3, Zhonghao Ji1,2, Hengzong Zhou1
1Department of Laboratory Animals College of Animal Sciences Jilin University Changchun China.
MedComm
|August 10, 2023
概括
新型纳米粒子通过刺激免疫反应来增强癌症免疫疗法. 基于脂质的纳米粒子在提供STING激动剂方面表现有前途,以提高抗瘤免疫力和改善治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI) 在抗瘤免疫力较低的患者中有效但有限.
- 刺激免疫激活通路为癌症免疫治疗提供了一种新的方法.
- 纳米技术使免疫调节剂的向输送成为可能,提高了疗效,减少了副作用.
研究的目的:
- 审查纳米颗粒用于癌症免疫瘤学的进展.
- 专注于基于脂质的纳米粒子 (脂质NP) 和它们在免疫治疗中的作用.
- 探索脂质-NP在增强STING激动剂治疗中的潜力.
主要方法:
- 关于纳米粒子在癌症免疫治疗中的当前文献的综述.
- 专注于基于脂质的纳米粒子及其特征.
- 分析STING通路激活及其在抗瘤免疫中的作用.
主要成果:
- 脂质-NP为向输送免疫调节剂提供了优势.
- 脂质-NP的STING通路激活可以促进抗瘤免疫力并调节瘤微环境.
- 通过脂质-NP递送的各种STING激动剂在临床前和临床环境中显示出潜力.
结论:
- 基于脂质的纳米颗粒是增强癌症免疫治疗的有希望的平台.
- 使用脂质-NP的STING激动剂的向输送可以克服当前免疫疗法的局限性.
- 需要进一步的研究来解决障碍,并优化脂质NP在临床应用中的使用.
相关概念视频
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


